ASH 2021 Conference Coverage on VuMedi
ASH 2021 on the Safety, Tolerability, PK/PD, and Preliminary Efficacy of NKTR-255, a Novel IL-15 Receptor Agonist, in R/R Hematologic Malignancies
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Nina Shah
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
Nina Shah
Login to view comments.
Click here to Login